Episode 1 – Dr Sri Gopal, Janssen Pharmaceuticals
Posted: 26 March 2021 | | No comments yet
In this episode, DTR’s Assistant Editor, Hannah Balfour, discusses the development of treatments for schizophrenia with Dr Srihari Gopal, the Head of Psychiatry research and development for the Neuroscience Therapeutic Area at Janssen Pharmaceuticals. They also explore some of the most exciting developments in the field, Janssen’s schizophrenia R&D focus, the knowledge gaps that Dr […]
In this episode, DTR’s Assistant Editor, Hannah Balfour, discusses the development of treatments for schizophrenia with Dr Srihari Gopal, the Head of Psychiatry research and development for the Neuroscience Therapeutic Area at Janssen Pharmaceuticals. They also explore some of the most exciting developments in the field, Janssen’s schizophrenia R&D focus, the knowledge gaps that Dr Gopal believes are key to developing more effective therapies and so much more!